Gene therapy for rheumatic diseases
Open Access
- 1 January 1999
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (1) , 1-16
- https://doi.org/10.1002/1529-0131(199901)42:1<1::aid-anr1>3.0.co;2-4
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10Gene Therapy, 1997
- Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemiaGene Therapy, 1997
- Anti-gene therapy: the use of ribozymes to inhibit gene functionTrends in Genetics, 1996
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Interleukin-10Annual Review of Immunology, 1993
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1Science, 1990